← AgentSite Network

insilico.com

AI-friendly mirror of insilico.com for archive, retrieval, and machine reading.

Total Pages
447
Total Words
269,252
Cache Generated
August 4, 2026
Resources
llms.txt— AI crawler index
sitemap.xml— XML sitemap
robots.txt— crawler directives
About this Cache— methodology and usage notes
Identity
primary.md— primary company profilepublic
identity.md— cache identity profilepublic
voice.md— voice and tone guidepublic
manifest.json— manifest metadatapublic
Content Index
▸website447 pages
Homepage
▸ir73 pages
▸media23 pages
insilico-dissemination-of-corporate-communications-final-pdf
terms-of-reference-for-the-remuneration-committee-e-pdf
PowerPoint Presentation
terms-of-reference-for-the-environmental-social-and-governance-committee-e-pdf
e_ham25121426ann-20251228-20251228_2337-pdf
… 18 more pages
▸en8 pages
Corporate Governance | Insilico Medicine
Investor Relations | Insilico Medicine
Listing Documents | Insilico Medicine
Announcements & Circulars | Insilico Medicine
Contact lR & Email Alert | Insilico Medicine
… 3 more pages
▸cn8 pages
投资者关系联络与邮件订阅 | 英矽智能
投资者关系 | 英矽智能
公告与通函 | 英矽智能
ESG | 英矽智能
网络直播与演示文稿 | 英矽智能
… 3 more pages
… 34 more pages
▸news_sc69 pages
英矽智能发布2026年中期盈利预喜
英矽智能发布 LabClaw 智能实验室系统，引领药物研发从“自动化”迈向“自主化”
AI创新切入千亿市场：英矽智能提名AI驱动的临床前候选化合物ISM9528用于疼痛管理
直击AACR 2026｜英矽智能携四项AI发现临床前研究成果亮相
BIO 2026圆满收官｜英矽智能达成25亿美元重磅合作，持续引领AI制药创新
… 64 more pages
PHD1/2 | Insilico Medicine
Using AI to Fight a Pandemic
Team | Insilico Medicine
▸blog18 pages
Expanding the Immuno-oncology Toolbox with an AI-discovered Target and Novel Inhibitor | Insilico Medicine
End-to-End AI-Driven Design of a First-in-Class PKMYT1 PROTAC Using Chemistry42
PCC | Insilico Medicine
FIH | Insilico Medicine
Automated data preparation for QSAR modeling
… 13 more pages
AI Accelerates Race for New Synthetic Lethality Therapeutics| Insilico Medicine
▸news93 pages
Insilico Medicine Announces 2025 Annual Results, Redefining Value Delivery in AI-Powered Drug Discovery
BIO Europe 2025 | Pushing the frontiers of generative AI for longevity, Insilico unveils portfolio of unique multiparameter-optimized cardiometabolic assets
Insilico Medicine Integrates Nach01 Foundation Model with Microsoft Discovery to Enable AI-Native, Enterprise-Ready Drug Discovery Workflows
Insilico Medicine Nominates ISM6200, a Potential Best-in-class Selective NR3C1 Inhibitor for Ovarian cancer, Cushing’s Syndrome, Hypercortisolism-associated obesity and Glaucoma
Insilico Announces Nature Medicine Publication of Phase IIa Results of Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis Discovered and Designed with a Pioneering AI Approach
… 88 more pages
3CLpro | Insilico Medicine
USP1 | Insilico Medicine
▸pipeline_target_cdk122 pages
CDK12/13 | Insilico Medicine
CDK12/13 | Insilico Medicine
view all 2 pages
Environmental Sustainability Consortium
▸events6 pages
AACR 2023 | Insilico Medicine
Insilico at AACR: Four Innovative Posters Demonstrating the Power of Generative AI
Insilico Medicine to Showcase AI-Driven Innovation at BIO 2026 International Convention
Insilico Medicine to Showcase at WHX 2026, Bridging Middle East–Global Partnerships to Accelerate Translational Research
BIO International Convention 2023 | Insilico Medicine
… 1 more pages
Security & IT | Insilico Medicine
Mission | Insilico Medicine
Nominating Novel USP1 Small Molecule Inhibitor as a Preclinical Candidate for BRCA mutant tumors| Insilico Medicine
▸pipeline17 pages
Pipeline | Insilico Medicine
TNIK | Insilico Medicine
QPCTL | Insilico Medicine
TEAD | Insilico Medicine
USP1 | Insilico Medicine
▸phd12 pages
PHD1/2 | Insilico Medicine
PHD1/2 | Insilico Medicine
… 10 more pages
Media Kit | Insilico Medicine
▸interactive17 pages
CO2 Capture
Oils and Lubricants
H2 storage
Sustainability Consortium
▸agrochemistry2 pages
Agrochemistry
Agrochemistry
▸drugs9 pages
Rentosertib
TEAD
QPCTL
KAT6
Garutadustat
… 4 more pages
▸longevity2 pages
Large Language of Life Models
Hallmarks of Aging
view all 17 pages
Case Study: Insilico's Transformation
ENPP1 | Insilico Medicine
▸pipeline_target_fgfr22 pages
FGFR2/3 | Insilico Medicine
FGFR2/3 | Insilico Medicine
view all 2 pages
MAT2A | Insilico Medicine
Pipeline | Insilico Medicine
Insilico Bench | Insilico Medicine
Drug Discovery Benchmark | Insilico Medicine
Contact us | Insilico Medicine
Insilico Science AI Bench | Insilico Medicine
▸mmai3 pages
End User Terms and Conditions
Privacy Policy
Science MMAI Gym
view all 3 pages
▸science423 pages
▸dora3 pages
End User Terms and Conditions | Science42:DORA
Privacy Policy | Science42:DORA
Cookies Policy | Science42: DORA | Insilico Medicine
view all 3 pages
Privacy Policy
Privacy Policy
Privacy Policy
团队 | Insilico Medicine
▸chemistry424 pages
end_user_terms
corporate_terms
privacy
chemistry42
view all 4 pages
聚焦“合成致死”策略，英矽智能发现靶向USP1的临床前候选药物，用于多种抗肿瘤疗法开发| Insilico Medicine
▸blog_cn4 pages
PCC CN | Insilico Medicine
PCC for Kidney Fibrosis | Insilico Medicine
Chemistry42 at NVIDIA GTC 2021CN | Insilico Medicine
Blog CN | Insilico Medicine
view all 4 pages
首页 | Insilico Medicine
管线 | Insilico Medicine
ISM6166, pan-KRAS Poster
llms.txt — Insilico Medicine
媒体资料包 | Insilico Medicine
Media Coverage | Insilico Medicine
MAT2A | Insilico Medicine
可持续发展 | Insilico Medicine
Équipe | Insilico Medicine
DGKA | Insilico Medicine
PHD1/2 | Insilico Medicine
生成式人工智能賦能 環境可持續性 聯盟 | Insilico Medicine
ENPP1 | Insilico Medicine
Cookies Policy
▸repository2 pages
Precious3GPT Data Repository | Insilico Medicine
Data Repository for TNIK | Insilico Medicine
view all 2 pages
使命 | Insilico Medicine
Inhaled Rentosertib (INS018_055) Safety Tolerability
TEAD | Insilico Medicine
联系方式 | Insilico Medicine
USP1 | Insilico Medicine
参会信息 | Insilico Medicine
ISM6260, CDK4 Poster
TNIK | Insilico Medicine
ISM3830, CBLB Poster
ISM1745, PRMT5 Poster
QPCTL | Insilico Medicine
人工智能预测的双重靶点| Insilico Medicine
Insilico Medicine: End-to-end generative AI-driven drug discovery and development
KAT6 | Insilico Medicine
Inhaled Rentosertib (INS018_055) Phase 1 Design
Inhaled Rentosertib (INS018_055) Lung exposure
PandaOmics | Insilico Medicine
利用英矽智能的人工智能平台，研究团队发现治疗ALS新希望 | Insilico Medicine
Insilico Medicine
DGKA | Insilico Medicine
Inhaled Rentosertib (INS018_055) Preclinical Efficacy Fibrosis
Dual-purpose therapeutic targets predicted using AI| Insilico Medicine
加入我们 | Insilico Medicine
From Start to Phase 1 in 30 Months | Insilico Medicine
Pharma.ai
3CLpro | Insilico Medicine
inClinico | Insilico Medicine
▸ism-events3 pages
▸abu-dhabi3 pages
BindHack: The Protein Affinity Hackathon | Insilico Medicine
Drug Discovery Hackathon | Insilico Medicine
Bioinformatics Hackathon | Insilico Medicine
view all 3 pages
Docuthon CN | Insilico Medicine
Chemistry42 | Insilico Medicine
KIF18A | Insilico Medicine
Docuthon | Insilico Medicine
TEAD | Insilico Medicine
Contactez-nous | Insilico Medicine
QPCTL | Insilico Medicine
KAT6 | Insilico Medicine
ISM001-055 Phase2a Biomarker Poster
ISM001-055 Phase2a Efficacy Poster
▸ism5411_phd13 pages
ISM5411, PHD1/2 Phase I Toxicology Poster
ISM5411, PHD1/2 T-cell Phase I Poster
ISM5411, PHD1/2 Phase I Clinical Poster
view all 3 pages
COVID-19 | Insilico Medicine
Biologie Générative | Insilico Medicine
ISM001-055 Phase2a HRCT Poster
Docuthon Judges | Insilico Medicine
Mission | Insilico Medicine
Why I Left Big Pharma for AI: Insilico Medicine’s Co-CEO Dr. Feng Ren| Insilico Medicine
Research Collaboration Using Insilico Medicine’s AI Yields New Treatment Possibilities for ALS | Insilico Medicine
ISM001-055 EFFICACY
ISM001-055 BIOMARKER
媒體工具包 | Insilico Medicine
Insilico & Nanome Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19
IMGAIA | Insilico Medicine
UEG WEEK 2025 Posters | Insilico Medicine
The next step in AI drug discovery: Robots| Insilico Medicine
▸pandaomics21 pages
▸help21 pages
Releases | PandaOmics
Prioritization Scores | PandaOmics
Druggability Filters | PandaOmics
Target ID | PandaOmics
Compound ID | PandaOmics
… 16 more pages
view all 21 pages
GENESIS-IPF HRCT 2025 Poster | Insilico Medicine
Careers | Insilico Medicine
Design Resources | Insilico Medicine
CB Insights Again Names Insilico Medicine One of the Top 100 AI Companies in the World| Insilico Medicine
Academic Grant Application | Insilico Medicine
主頁  | Insilico Medicine
團隊 | Insilico Medicine
TNIK | Insilico Medicine
Publications | Insilico Medicine
使命 | Insilico Medicine
聯絡我們 | Insilico Medicine
管線 | Insilico Medicine
ISM Structure
Request access | PandaOmics
新聞發布 | Insilico Medicine
3D
職業發展 | Insilico Medicine